MAPK1 and Alzheimer disease: Thus, in our study, we showed that the mitochondrial antioxidant SkQ1 reduces the accumulation of Aβ in the hippocampus of senescence-accelerated OXYS rats during AD-like pathology by suppressing p38 MAPKsp activity.